藥碼
TET01
藥名
DTaP-IPV
英文商品名
Tetraxim 公費四合一 0.5 mL
中文商品名
巴斯德四合一疫苗
螢幕名
Tetraxim 公費四合一 0.5 mL
劑型
Inj
規格
成分
藥理分類
Toxoids
健保碼
X000154206
ATC碼
藥品圖片
外觀圖片
適應症
Diphtheria, tetanus, pertussis, and poliovirus disease prevention
藥理
Promotes active immunity to diphtheria, tetanus, pertussis, and poliovirus (types 1, 2 and 3) by inducing production of specific antibodies and antitoxins.
藥動學
禁忌症
Severe allergic reaction (eg, anaphylaxis) after a previous dose of any diphtheria toxoid, tetanus toxoid, pertussis-containing vaccine, or inactivated poliovirus vaccine, or to any component of DTaP/IPV, including neomycin and polymyxin B; encephalopathy (eg, coma, decreased level of consciousness, prolonged seizures) within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause; progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy.(UTD)
懷孕分類
C (FDA)
哺乳分類
Infant risk cannot be ruled out.(MDX)
副作用
>10%:
Cardiovascular: Swelling of injected limb (arm circumference increase: 36% to 68%), swelling of injected limb (extensive, 2%)
Central nervous system: Malaise (35%), drowsiness (19%), headache (16%)
Gastrointestinal: Decreased appetite (16%)
Local: Injection site: Pain at injection site (57% to 77%), erythema at injection site (37% to 59%), swelling (26% to 40%) Neuromuscular & skeletal: Myalgia (54%)
Miscellaneous: Fever (6% to 16%)
劑量和給藥方法
Vaccination for diphtheria, pertussis, and tetanus:
(6 weeks to younger than 7 years) 0.5 mL IM for 5 doses at 2, 4, and 6 months of age (at 6- to 8-week intervals), at 15 to 20 months, and at 4 to 6 years. Doses 4 and 5 are boosters for diphtheria and tetanus and dose 5 is a booster for pertussis
(Booster) If 4 doses of Pentacel(R) have been administered, give Daptacel(R) 0.5 mL IM as the fifth dose
(6 weeks to younger than 7 years) 0.5 mL IM for 5 doses at 2, 4, and 6 months of age, and boosters at 15 to 18 months and at 4 to 6 years; fourth dose may be given as early as age 12 months provided 6 months have elapsed since the third dose
(4 years or older) If fourth dose administered at 4 years or older, do not administer fifth dose .
小兒調整劑量
腎功能調整劑量
肝功能調整劑量
安定性
Store between 2 to 8 degrees.
藥袋資訊
臨床用途
(公費)白喉、破傷風、百日咳及小兒麻痺四合一疫苗
主要副作用
注射部位疼痛、疲倦、頭痛、發燒
泡製方法
儲存方式
請置於 2-8℃ 冷藏儲存
注意事項
其他說明
藥局 X4 | 藥庫 門公
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
自費價
仿單
資料庫
健保給付規定